FSD Pharma Inc.

NASDAQ (USD): FSD Pharma Inc. (HUGE)

Last Price

0.09

Today's Change

-0.01 (10.00%)

Day's Change

0.087 - 0.104

Trading Volume

21,491,684

Overview

Market Cap

66,671

Shares Outstanding

741,612

Avg Volume

196,163

Avg Price (50 Days)

8.13

Avg Price (200 Days)

36.69

PE Ratio

-0.01

EPS

-16.25

Earnings Announcement

12-Nov-2024

Previous Close

0.10

Open

0.10

Day's Range

0.087 - 0.1042

Year Range

0.087 - 109.1935

Trading Volume

22,015,006

Price Change Highlight

1 Day Change

0.00%

5 Day Change

-97.74%

1 Month Change

-98.47%

3 Month Change

-99.41%

6 Month Change

-99.83%

Ytd Change

-99.85%

1 Year Change

-99.89%

3 Year Change

-99.92%

5 Year Change

-99.99%

10 Year Change

-99.99%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment